Summary of Purpose
To determine whether intravenous magnesium sulfate initiated within 12 hours of symptom onset will reduce the frequency of infarct growth, as measured by MRI, in ischemic stroke patients.Read More →
The following dates are available for this trial. Trial information last updated on 19 May 2009.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- National Institute for Neurological Disorders and Stroke, NIH
Randomized, double-blind, placebo-controlled, multicenter trial. This is an MRI substudy of the IMAGES trial.